Health Condition 1: S023- Fracture of orbital floor
Conditions
Interventions
Intervention1: Polycaprolactone Mesh: Polycaprolactone Mesh is composed of biocompatible plastic polycaprolactone belonging to the aliphatic polyester family. Approved by USFDA. It has osteoconductive
Sponsors
Vishesh Bhardwaj
Eligibility
Inclusion criteria
Inclusion criteria: Orbital floor fractures indicated for reconstruction Patients should be medically fit in accordance with ASA grade assessment (limited to ASA grade 1 and grade 2) Size of the defect should be limited between 6mm to 20mm
Exclusion criteria
Exclusion criteria: Patients with comminuted fractures in orbital region Any pathologies or infections in orbital region Fracture older than 2 weeks Patient with loss of vision following trauma Non compliant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of polycaprolactone Mesh and Titanium mesh in management of orbital floor fracture To evaluate and compare polycaprolactone Mesh and Titanium mesh in the management of orbital floor fractureTimepoint: Post operatively 1 week 1 month and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical assessment of ocular functions Enophthalmous, Extra occular muscle movement impairment and diplopia Radiological assessment using CT/CBCTTimepoint: Post operatively 1 week 1 month and 3 months | — |
Countries
India
Contacts
Public ContactVishesh Bhardwaj
AJ Institute of Dental Sciences
Outcome results
None listed